Results
1
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
1 companies
OSE Immunotherapeutics
Market Cap: €135.2m
A clinical-stage biotechnology company, develops immunotherapies in the areas of immune-oncology and immune-inflammation in France and internationally.
OSE
€6.03
7D
0.5%
1Y
-40.1%